Vision specialist Gensight eyes a €90M IPO on NASDAQ
French Gensight intends to raise one of the biggest European IPOs on the American stock…
As one of the biggest success stories of the 21st century, gene therapy is providing hope for treating diseases that once seemed incurable. Any genetic mutation causing disease could theoretically be fixed by inserting a new copy of the faulty gene. This means that gene therapy has the potential to treat some previously incurable conditions with a single dose.
By 2025, the FDA expects to approve between 10 and 20 gene therapies each year, and we are already seeing an increase in the number of approvals today. However, the field continues to face a number of obstacles ranging from safety concerns to manufacturing shortages. Read on to get the latest in the gene therapy field.
Gene Therapy Industry Report 2021
In this report, we take a closer look at the growing gene therapy market, current development and manufacturing challenges, and the exciting future ahead for this industry.
Go to ReportFrench Gensight intends to raise one of the biggest European IPOs on the American stock…
Good news for patients suffering from cystic fibrosis! Imperial Innovations' patented gene therapy could improve…
The biggest biocluster of the World is still attractive. Munich-based Sirion Biotech decided to open…
ASCO Annual Meeting keeps bringing positive results of European companies that cross the ocean to…
Selecta Biosciences and Généthon are collaborating to enable repeat dosing for gene therapies. The companies…
GlaxoSmithKline has become the first big pharma company to file a gene therapy approval case to the…
Gene Therapy is really the hot topic right now in the field of Biotech especially with…
Synpromics has formed a collaboration with uniQure, the Dutch pioneer in human gene therapy, to…
THERAVECTYS, a fully-integrated discovery and clinical development biotechnology company focusing on the development of therapeutic vaccines and immunotherapy,…
What could you buy with €1,1M euros? A house? Or a single prescription for a new…